Zhejiang Peptites Biotech Co., Ltd.

Founded in 2015, Zhejiang Peptites Biotech Co., Ltd. has rapidly grown into a leader in the field of peptide active pharmaceutical ingredients (APIs). ZPC focuses on the R&D and large-scale production of APIs. Backed by 79 patents, over 700 employees, and a R&D team of more than 150 researchers, ZPC has rich experience in IND, NDA and ANDA API declaration. Currently, the construction of the Phase 3 plant has commenced, spanning an area of 600 acres, with the aim of establishing China's large-scale peptide industrial park and a peptide central research institute.